Published in
Springer, Breast Cancer Research and Treatment, 3(193), p. 565-565, 2022
DOI: 10.1007/s10549-022-06613-4
Links
Tools
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Journal article published in 2022 by
Charles E. Geyer 
,
Hanna Bandos,
Priya Rastogi,
Samuel A. Jacobs,
André Robidoux,
Louis Fehrenbacher,
Patrick J. Ward ,
Jonathan Polikoff,
Adam M. Brufsky,
Louise Provencher,
Alexander H. G. Paterson,
John T. Hamm,
Robert L. Carolla,
Luis Baez-Diaz,
Thomas B. Julian
and other authors.
,
Hanna Bandos,
Priya Rastogi,
Samuel A. Jacobs,
André Robidoux,
Louis Fehrenbacher,
Patrick J. Ward ,
Jonathan Polikoff,
Adam M. Brufsky,
Louise Provencher,
Alexander H. G. Paterson,
John T. Hamm,
Robert L. Carolla,
Luis Baez-Diaz,
Thomas B. Julian
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 